Lishan Su

Title: Lishan Su: Innovator in Type I Interferon Research

Introduction

Lishan Su is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies targeting the type I interferon alpha receptor. His work has the potential to impact the treatment and diagnosis of various diseases mediated by type I interferons.

Latest Patents

Lishan Su holds a patent for a "Type I interferon receptor antibody and use thereof." This patent discloses monoclonal antibodies that bind to the type I interferon alpha receptor. The antibodies are capable of inhibiting the biological activity of type I interferons, making them useful for treating, preventing, or diagnosing diseases associated with these interferons. Additionally, the patent includes details on immunoconjugates, bispecific molecules, and pharmaceutical compositions that incorporate these antibodies.

Career Highlights

Lishan Su is affiliated with the Chinese Academy of Sciences, where he conducts his research. His innovative work in the field of immunology has garnered attention and recognition within the scientific community. He has successfully developed a patent that showcases his expertise and commitment to advancing medical science.

Collaborations

Lishan Su collaborates with notable colleagues, including Liguo Zhang and Jingyun Li. These partnerships enhance the research efforts and contribute to the development of groundbreaking therapies.

Conclusion

Lishan Su is a key figure in the field of immunology, with a focus on type I interferon receptor antibodies. His patent and ongoing research hold promise for future advancements in the treatment of diseases related to type I interferons.